Consent to the Distribution of a Changed Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Lamivudine 100 mg Tablet, film coated Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Zeffix Note: This consent is valid for 2 years from the date of publication of this notice. Dated this 14th day of September 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.